共 50 条
Comparing Guidelines for the Treatment of Inflammatory Bowel Disease
被引:0
|作者:
Hanauer, Stephen B.
[1
]
Kirsner, Joseph B.
[1
]
机构:
[1] Univ Chicago Med, Sect Gastroenterol Hepatol & Nutr, Chicago, IL 60637 USA
关键词:
CROHNS-DISEASE;
EFFICACY;
5-AMINOSALICYLATES;
INFLIXIMAB;
THERAPY;
D O I:
10.1159/000354695
中图分类号:
R57 [消化系及腹部疾病];
学科分类号:
摘要:
As we enter into the era of 'personalized medicine', many of the recommendations of 'evidence-based medicine' require scrutiny and adaptation to optimize individual outcomes. Several examples of these discrepancies are exemplified by the topics of aminosalicylate use in Crohn's disease, early use of biologic agents that target TNF and the role of calcineurin inhibitors versus anti-TNF agents in steroid-refractory ulcerative colitis. (C) 2013 S.Karger AG, Basel
引用
收藏
页码:360 / 362
页数:3
相关论文